JOHNSON & JOHNSON — Director's Dealing 2025

Feb 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-02-14

Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-14	Common Stock	M	2806	—	Acquired	17904	Direct
2025-02-14	Common Stock	F	1015	$156.71	Disposed	16889	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-14	Performance Share Units	$	M	2806	Disposed		Common Stock (2806)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	722	Indirect
Common Stock	46	Indirect

Footnotes

F1: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 14, 2022.

F2: Shares withheld for payment of taxes upon vesting of PSUs.

F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).

F4: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2025).